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Alginate overproduction by Pseudomonas aeruginosa, or mucoidy, plays an important role in the pathogenesis of chronic lung
infections in cystic fibrosis (CF) patients. Here we report the draft genome sequence of a clinical isolate of mucoid P. aeruginosa
strain C7447m from a CF patient with chronic lung infection.
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Overproduction of the capsular polysaccharide alginate bythe Gram-negative bacterium Pseudomonas aeruginosa is a
hallmark of chronic lung infections in cystic fibrosis (CF)
patients. Among its many roles in virulence, alginate protects
the bacteria from host defenses (1) and antibiotic chemotherapy
(2). Here, we report the genome sequence of a clinical alginate-
overproducing, mucoid P. aeruginosa isolate, C7447m. Strain
C7447m was originally isolated from a CF patient in 1997 by Da-
vid P. Speert in Vancouver, British Columbia, Canada.
Genomic DNA extracted by cetyltrimethylammonium bro-
mide (CTAB)-NaCl and phenol-chloroform-isoamyl alcohol
was sent to Cofactor Genomics (St. Louis, MO). Paired-end
sequencing libraries were generated according to vendor pro-
tocols (Illumina, San Diego, CA). The genome sequencing was
performed on an Illumina GAIIX. Totals of 11,770,660 raw
reads and 1,883,305,600 bp were obtained. The sequence data
were generated and assembled using Illumina Pipeline version
SCS 2.8.0 based on paired-end tags with OLB 1.8.0. The se-
quences were then aligned and annotated according to the ref-
erence strain PAO1 genome (GenBank accession no.
NC_2516.2) by use of the Novocraft novoAlign v 2.07.13 soft-
ware package. Further analysis of the genome was performed
using Samtools version 01.15c for the generation of pileup after
sorting and the removal of duplicate reads. The analysis pipe-
line software was developed by CoFactor Genomics, and all
specifics regarding aligner algorithms can be obtained from
Novocraft Technologies. In summary, the number of generated
base pairs resulted in approximately 224 coverage of the ref-
erence PAO1 genome. The number of base pairs saturated at or
above 8 is 6,088,140 (97.19%), and the number of base pairs
saturated below 8 is 176,264 (2.81%). The genome was an-
notated and prepared for submission using Ergatis-based
workflow with manual correction.
The analysis results of single nucleotide polymorphisms
(SNPs) and indels showed that 643 heterozygous mutants (255
indels and 388 SNPs; count ratios of 0.4 and 0.6) and
25,753 homozygous SNPs (count ratio,0.6) were found. The
count ratio is defined as the number of times the reference base
is observed divided by the coverage at this base (counting all
matches and mismatches). Only 14 indels, with coverage at the
site above 8 and the mutant to wild type ratios at 2, were
included in this genome edition. Thirteen of the included in-
dels were distributed in the intergenic region. Among the ho-
mozygous SNPs, 22,439 mutations were distributed in 4,516
genes/coding sequence (CDS) (which accounts for 79.47% of
the total genes/CDS), and 3,314 mutations were identified in
the intergenic region. Most of the mutant genes have multiple
SNPs, and 2,846 genes/CDS have 3 or more homozygous SNPs.
Despite the mucoid phenotype, the strain C7447m has wild-
type algU andmucA. Furthermore, among previously reported
alginate production-related genes (3–6), the amino acid se-
quences of MucC, MucD, AlgL, and KinB each have 1 amino
acid change; AlgX has 2 amino acid changes; and AlgI and AlgP
have 5 amino acid changes. We also found some SNPs located
in the intergenic region before algB, algC, algD, amrZ, clpP2,
mucE, mucR, and pilA.
Nucleotide sequence accessionnumber.Thedraft genome se-
quence of C7447mhas been deposited in GenBankwith the acces-
sion number CP006728.
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